Actinium Pharmaceuticals Inc Capital Reinvestment Ratio
Actinium Pharmaceuticals Inc capital reinvestment ratio. Actinium Pharmaceuticals Inc (ATNM) has a Capital Reinvestment Ratio of 0.01x as of June 2022, meaning it reinvests 0% of its operating cash flow ($27.92 Million) in capital expenditures ($270.00K). Check ATNM cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Actinium Pharmaceuticals Inc (2022–2022)
Capital reinvestment ratio of Actinium Pharmaceuticals Inc from 2022 to 2022. This chart tracks Actinium Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is Actinium Pharmaceuticals Inc growing its equity to track the company's year-over-year net asset growth rate.
Actinium Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2022–2022)
Actinium Pharmaceuticals Inc capital reinvestment ratio by year from 2022 to 2022. For the full cash flow conversion analysis, see cash flow conversion of Actinium Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.04x | $8.64 Million | $366.00K | — |